Skip to Content

Drug Interactions between Hecoria and Sensipar

This report displays the potential drug interactions for the following 2 drugs:

  • Hecoria (tacrolimus)
  • Sensipar (cinacalcet)

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Hecoria and Sensipar. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Hecoria

A total of 722 drugs are known to interact with Hecoria.

Sensipar

A total of 121 drugs are known to interact with Sensipar.

Drug and food interactions

Moderate

tacrolimus food

Applies to: Hecoria (tacrolimus)

Tacrolimus should be taken on a consistent schedule before or after you eat at the same times each day. Grapefruit and grapefruit juice may increase the amount of tacrolimus in your body. This can lead to potentially dangerous side effects and should be avoided. If you are already consuming grapefruit products, do not increase or decrease the amount of these products in your diet without first talking to your doctor.

Switch to professional interaction data

Moderate

cinacalcet food

Applies to: Sensipar (cinacalcet)

Food can enhance the levels of cinacalcet in your body. Cinacalcet should be taken just after eating food. Do not take it on an empty stomach. This will make it easier for your body to absorb the medication. Do not crush, chew, or break the tablets. Swallow them whole.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.